Cargando…
Biomimetic nanotherapy: core–shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma
BACKGROUND: Non-Hodgkin’s lymphoma (NHL) is a malignant disease of lymphoid tissue. At present, chemotherapy is still the main method for the treatment of NHL. R-CHOP can significantly improve the survival rate of patients. Unfortunately, DOX is the main cytotoxic drug in R-CHOP and it can lead to a...
Autores principales: | Zhao, Qiangqiang, Jiang, Duanfeng, Sun, Xiaoying, Mo, Qiuyu, Chen, Shaobin, Chen, Wansong, Gui, Rong, Ma, Xianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201715/ https://www.ncbi.nlm.nih.gov/pubmed/34120620 http://dx.doi.org/10.1186/s12951-021-00922-4 |
Ejemplares similares
-
Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management
por: Wang, Yi, et al.
Publicado: (2019) -
Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases
por: Yang, Guoyu, et al.
Publicado: (2019) -
Pyruvate dehydrogenase kinase 4‐mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B‐cell lymphoma by affecting the expression of MS4A1/CD20
por: Jiang, Duanfeng, et al.
Publicado: (2021) -
Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma
por: Zhao, Qiangqiang, et al.
Publicado: (2021) -
Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases
por: Li, Chen-Wen, et al.
Publicado: (2020)